Hello and thanks for joining us to discuss Vertex Inc third quarter financial results. I'm Joe Crivelli, Vice President, Investor Relations, David DiStefano, our President and CEO and John Schwab. Our ...
Q3 2024 Earnings Call Transcript November 6, 2024 Operator: Good day, and welcome to the Vertex Inc. Third Quarter 2024 ...
Q3 2024 Earnings Conference Call November 6, 2024 8:30 AM ETCompany ParticipantsJoe Crivelli - Vice President, ...
Workday Recognized as a Leader in 2024 Gartner® Magic Quadrant(TM) for Cloud ERP for Service-Centric Enterprises for Third Consecutive Year ...
CASGEVY approved for the treatment of patients 12 years of age and older with sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT) in Switzerland and Canada- -45 authorized treat ...
-CASGEVY™ approved for the treatment of patients 12 years of age and older with sickle cell disease (SCD) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback